Levi & Korsinsky Launches Fraud Investigation on Behalf of UroGen Pharma Ltd. (URGN) Shareholders
NEW YORK, NY / ACCESS Newswire / May 29, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of UroGen Pharma Ltd. ("UroGen Pharma Ltd.") (NASDAQ:URGN) concerning possible violations of federal securities laws. On May 16, 2025, the FDA stated: "Given that ENVISION lacked a concurrent control arm, the primary endpoints […]